Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (177)

2024

  1. Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study

    Circulation. Cardiovascular imaging, Vol. 17, Núm. 1, pp. e016206

  2. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97

2023

  1. Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study

    Circulation, Vol. 147, Núm. 19, pp. 1436-1443

  2. Cardiovascular Risk Scores: Great Tools… When Used by Good Physicians

    Revista Argentina de Cardiologia

  3. Cardiovascular Risk Scores: Great Tools… When Used by Good Physicians

    Revista Argentina de Cardiologia

  4. Icosapent ethyl in reducing residual risk. New evidence

    Revista Espanola de Cardiologia Suplementos, Vol. 23, Núm. SA, pp. 15-19

  5. Intracoronary thrombus assessment with cardiac computed tomography angiography in a deferred stenting strategy: The MATURE prospective study (MSCT to Assess ThrombUs REsolution)

    Coronary Artery Disease, Vol. 34, Núm. 3, pp. 167-176

  6. Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study

    European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 320-328

  7. Relevance of subclinical right ventricular dysfunction measured by feature-tracking cardiac magnetic resonance in non-ischemic dilated cardiomyopathy

    BMC Cardiovascular Disorders, Vol. 23, Núm. 1

  8. Response by Pérez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study"

    Circulation

2022

  1. Impact of previous cardiac function status assessed by echocardiography on the outcome of COVID-19

    Scientific Reports, Vol. 12, Núm. 1

  2. Is it Time for Single-Pill Combinations in Dyslipidemia?

    American Journal of Cardiovascular Drugs, Vol. 22, Núm. 3, pp. 239-249

  3. Relationship between the coronary artery calcium quantification and gut microbiota composition in subjects without previous cardiovascular disease: A pilot study

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 4, pp. 205-215

  4. TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice

    Cardiology Journal, Vol. 29, Núm. 5, pp. 730-738

2021

  1. Dyslipidemia and aortic valve disease

    Current opinion in lipidology, Vol. 32, Núm. 6, pp. 349-354

  2. Myocardial strain in nonischemic dilated cardiomyopathy with feature tracking. Feasibility and prognostic implications

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 159-166

  3. The degenerative aortic stenosis challenge: health care resources adjustment to demographic change

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 71-73

2020

  1. Circumflex Artery Arising From the Pulmonary Artery: Always a Malignant Coronary Anomaly?

    Journal of Cleaner Production

  2. Circumflex Artery Arising From the Pulmonary Artery: Always a Malignant Coronary Anomaly?

    JACC: Case Reports, Vol. 2, Núm. 11, pp. 1702-1707

  3. Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 828-834